🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Another milestone for affordable healthcare in Maharashtra. Two complex TAVI surgeries performed in a tribal region of Maharashtra, by world-renowned cardiologist Prof. Jan Kovach at SMBT Heart Institute. SMBT Charitable Hospital

Excellent article by Dr Kharya promoting CGT in India.

🎥 𝗣𝗿𝗮𝗱𝗲𝗲𝗽 𝗦𝗶𝗻𝗴𝗵'𝘀 𝗷𝗼𝘂𝗿𝗻𝗲𝘆 𝘄𝗶𝘁𝗵 𝗡𝗲𝘅𝗖𝗔𝗥𝟭𝟵 #CART #CancerSurvivor #NexCAR19 #Immunotherapy #LeukemiaSurvivor #CancerTreatmentInIndia #ImmunoACT Rahul Purwar Hasmukh Jain shirish arya IIT Bombay ACTREC-TMC Tata Memorial Hospital TataMemorialCentre75 National Cancer Institute

Thanks Deepak for the encouragement and wishes! We are blessed to have friends and colleagues like you.

Our recent publication in The Lancet Hematology highlights the clinical trials data on registration trial for NexCAR19 (73%ORR, no ICANS, minimal CRS) and it's access to LMICs ImmunoACT Rahul Purwar

Startup of the year 2024- ImmunoACT via BioSpectrumAsia

Join us virtually for the CAR-T Summit 2025 on April 12–13! 🌐 Connect with global experts in cell and gene therapy and explore the future of personalized cancer care. Livestream worldwide—don’t miss it! 🔗Join now: lnkd.in/gZWSBk68 #CARTSummit2025 #CancerCare #ImmunoACT

We encourage you to join today’s insightful sessions and be a part of the ongoing dialogue shaping the future of healthcare!! #ImmunoACT #NexCAR19 #CARTSummit2025 Rahul Purwar shirish arya Hasmukh Jain Tata Memorial Hospital ACTREC-TMC Atharva Karulkar shreshtha shah

We're proud to lead India's journey in making CAR-T cell therapy more accessible for patients across the world. This article by Moneycontrol highlights how India is becoming a destination for international patients seeking CAR-T therapy - bolstered by its affordability,

At #CARTSummit2025, Dr. Jitendra Kumar, Managing Director at Biotechnology Industry Research Assistance Council (BIRAC), delivered a powerful session on enabling India’s CAR-T landscape through strategic support and innovation. He highlighted BIRAC’s pivotal role in bridging

2012 a friend said- “Science Fiction” 2015 we dared to dream Sharing 🇮🇳 1st novel #CARTCellRx Ph 1/1b trial We report 92% ORR 3 dose levels nature Blood Cancer Journal Rahul Purwar ImmunoACT CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC Nirali Shah Tata Memorial Hospital Swaminathan K Alka Dwivedi rdcu.be/ei7xh

Exciting milestone in CAR T Cell Therapy for pediatric patients!!! rdcu.be/ei7xh Gaurav Narula MD Albeena Nisar deepalipandit1993 Rahul Purwar Atharva Karulkar Tata Memorial Hospital ACTREC-TMC IIT Bombay ImmunoACT

At #CARTSummit2025, Ms. Shalini Jatia, Officer in Charge at ImPaCCT Foundation, Tata Memorial Centre, led a powerful session titled “Patient Journey: Learning the Patient's Journey in the Patient's Own Voice.” The session brought to the stage eight CAR-T therapy recipients who

Thanks to Department of Biotechnology DBT-BIRAC and Dr Gokhale for highlighting the CAR-T as science with compassion, access and affordability. We will continue to work hard to improve access of such high quality-life saving medicines at affordable cost. Dr Jitendra Singh IIT Bombay ImmunoACT

Truly an honor discussing some of our work at THSTI, a DBT institute. Interacted with friends, colleagues and students. Thanks a lot DBT-THSTI , Dr Karthikeye, Dr Amit, Dr Batra and entire team for the invite and warm hospitality.

🌟 Proud Moment! 🌟 We performed the first CAR-T cell therapy in Punjab and the northern Indian region for a patient with refractory B-ALL. This makes us one of the first few institutions in India to offer this level of treatment. ImmunoACT

𝗪𝗼𝗿𝗹𝗱 𝗕𝗹𝗼𝗼𝗱 𝗖𝗮𝗻𝗰𝗲𝗿 𝗗𝗮𝘆 𝗦𝗲𝗿𝗶𝗲𝘀 | 𝗗𝗮𝘆 𝟭 – 𝗟𝗲𝘁’𝘀 𝗧𝗮𝗹𝗸 𝗔𝗯𝗼𝘂𝘁 𝗟𝘆𝗺𝗽𝗵𝗼𝗺𝗮 Behind every cancer statistic is a person, a family, a story. In India, over 𝟯𝟵,𝟬𝟬𝟬 people are diagnosed with lymphoma each year - and 𝟮𝟮,𝟬𝟬𝟬 don’t make

𝗪𝗲’𝗿𝗲 𝗟𝗶𝘃𝗲! 𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗔𝗹𝗹-𝗡𝗲𝘄 𝗜𝗺𝗺𝘂𝗻𝗼𝗔𝗖𝗧 𝗪𝗲𝗯𝘀𝗶𝘁𝗲 Our new website is here - with a fresh design, smoother navigation, and everything you need to know about our CAR-T journey. Explore our product pipeline, learn more about #NexCAR19,

Join us for an insightful webinar featuring 𝗗𝗿. 𝗩𝗶𝗽𝘂𝗹 𝗦𝗵𝗲𝘁𝗵, a leading Hemato-oncologist in India, as he unpacks the "Escape Mechanism in CAR-T Cell Therapy". This session will delve into the scientific basis of escape pathways, clinical experiences, and their impact

We are honored to share the journey of Korak Abdulla Muhamad, the first patient from Yatharth Super Speciality Hospitals to receive #NexCAR19. In this inspiring testimonial, Korak reflects on his recovery from relapsed blood cancer through CAR-T cell therapy. Congratulations to